183 related articles for article (PubMed ID: 36366457)
1. The Elevated De Ritis Ratio on Admission Is Independently Associated with Mortality in COVID-19 Patients.
Drácz B; Czompa D; Müllner K; Hagymási K; Miheller P; Székely H; Papp V; Horváth M; Hritz I; Szijártó A; Werling K
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366457
[TBL] [Abstract][Full Text] [Related]
2. The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients.
Zinellu A; Arru F; De Vito A; Sassu A; Valdes G; Scano V; Zinellu E; Perra R; Madeddu G; Carru C; Pirina P; Mangoni AA; Babudieri S; Fois AG
Eur J Clin Invest; 2021 Jan; 51(1):e13427. PubMed ID: 33043447
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of De Ritis ratio with aspartate aminotransferase and alanine aminotransferase within the reference range.
Ndrepepa G; Holdenrieder S; Kastrati A
Clin Chim Acta; 2023 Jan; 538():46-52. PubMed ID: 36370837
[TBL] [Abstract][Full Text] [Related]
4. The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients.
Wang H; Fang K; Zhang J; Jiang Y; Wang G; Zhang H; Chen T; Shi X; Li Y; Duan F; Liu J
Int Urol Nephrol; 2017 Aug; 49(8):1391-1398. PubMed ID: 28550473
[TBL] [Abstract][Full Text] [Related]
5. The reversed De Ritis ratio for predicting in-hospital mortality among intensive care patients with organophosphate poisoning.
Nafea O; Ibrahim F; Abdelhamid W
Biomarkers; 2023 Feb; 28(1):111-117. PubMed ID: 36377078
[TBL] [Abstract][Full Text] [Related]
6. Aspartate transaminase/alanine transaminase (De Ritis ratio) predicts survival in major burn patients.
Wang B; Hu L; Chen Y; Zhu B; Kong W; Zhu Z; Wang K; Yu Q; Zhang W; Wu G; Sun Y; Xia Z
Burns; 2022 Jun; 48(4):872-879. PubMed ID: 34456097
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of aspartate aminotransferase-to-alanine aminotransferase ratio for contrast-associated acute kidney injury in patients undergoing elective percutaneous coronary intervention.
He HM; He C; Zhang SC; You ZB; Lin XQ; Luo MQ; Lin MQ; Guo YS; Zheng WP; Lin KY
J Cardiol; 2022 May; 79(5):618-625. PubMed ID: 34857433
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of De Ritis (AST/ALT), ALP/ALT, and AST/ALP ratios as prognostic factors in patients with acute ischemic stroke.
Ahmadabad MA; Naeimi A; Keymoradzadeh A; Faghani S; Ahmadabad MA; Boroujeni NA; Mohammadpour H; Saberi A
BMC Neurol; 2022 Dec; 22(1):450. PubMed ID: 36463106
[TBL] [Abstract][Full Text] [Related]
9. De Ritis ratio and biochemical parameters in COVID-19 patients.
Yazar H; Kayacan Y; Ozdin M
Arch Physiol Biochem; 2022 Dec; 128(6):1676-1680. PubMed ID: 32683882
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy.
Gorgel SN; Kose O; Koc EM; Ates E; Akin Y; Yilmaz Y
Int Urol Nephrol; 2017 Sep; 49(9):1577-1583. PubMed ID: 28669104
[TBL] [Abstract][Full Text] [Related]
11. Association of De Ritis Ratio with Prognosis in Patients with Coronary Artery Disease and Aminotransferase Activity within and outside the Healthy Values of Reference Range.
Ndrepepa G; Cassese S; Scalamogna M; Lahu S; Aytekin A; Xhepa E; Schunkert H; Kastrati A
J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176615
[TBL] [Abstract][Full Text] [Related]
12. The Study of De Ritis (Ast/ Alt) Ratio in Comparision with Other Parameters for Predicting Poor Prognosis in Covid 19 Patients.
A Y; R V
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443478
[TBL] [Abstract][Full Text] [Related]
13. Elevated De Ritis Ratio Is Associated With Poor Prognosis in COVID-19: A Systematic Review and Meta-Analysis.
Pranata R; Huang I; Lim MA; Yonas E; Vania R; Lukito AA; Nasution SA; Siswanto BB; Kuswardhani RAT
Front Med (Lausanne); 2021; 8():676581. PubMed ID: 35004709
[No Abstract] [Full Text] [Related]
14. De Ritis (aspartate transaminase/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with upper urinary tract urothelial carcinoma following nephroureterectomy.
Nishikawa M; Miyake H; Fujisawa M
Urol Oncol; 2016 Sep; 34(9):417.e9-417.e15. PubMed ID: 27180325
[TBL] [Abstract][Full Text] [Related]
15. The utility of De Ritis Ratio in predicting prognosis in testicular cancer.
Guner E; Seker KG; Arikan Y; Huseynov C; Sam E; Ozdal OL
Aktuelle Urol; 2020 Jun; 51(3):285-289. PubMed ID: 32135561
[TBL] [Abstract][Full Text] [Related]
16. An Updated Systematic Review and Meta-Analysis of the Association between the De Ritis Ratio and Disease Severity and Mortality in Patients with COVID-19.
Mangoni AA; Zinellu A
Life (Basel); 2023 Jun; 13(6):. PubMed ID: 37374107
[TBL] [Abstract][Full Text] [Related]
17. De-Ritis Ratio Is Associated with Mortality after Cardiac Arrest.
Lu Z; Ma G; Chen L
Dis Markers; 2020; 2020():8826318. PubMed ID: 33204363
[TBL] [Abstract][Full Text] [Related]
18. The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma.
Cho YH; Hwang JE; Chung HS; Kim MS; Hwang EC; Jung SI; Kang TW; Kwon DD; Choi SH; Kim HT; Kim TH; Kwon TG; Noh JH; Kim MK; Kim CS; Kang SG; Kang SH; Cheon J; Lee CH; Ku JY; Ha HK; Tae BS; Jeong CW; Ku JH; Kwak C; Kim HH
Int Urol Nephrol; 2017 Aug; 49(8):1383-1390. PubMed ID: 28484945
[TBL] [Abstract][Full Text] [Related]
19. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
[TBL] [Abstract][Full Text] [Related]
20. The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis.
Yin G; Man C; Liao S; Qiu H
Mediators Inflamm; 2020; 2020():5719751. PubMed ID: 33376452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
